77
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Predictive and Prognostic Potentials of Lymphocyte-C-Reactive Protein Ratio Upon Hospitalization in Adult Patients with Acute Pancreatitis

, ORCID Icon, , , , , , , , , , , , , & show all
Pages 1659-1669 | Received 19 Nov 2023, Accepted 07 Mar 2024, Published online: 13 Mar 2024

References

  • Shi N, Sun GD, Ji YY, et al. Effects of acute kidney injury on acute pancreatitis patients’ survival rate in intensive care unit: a retrospective study. World J Gastroenterol. 2021;27(38):6453–6464. doi:10.3748/wjg.v27.i38.6453
  • Sundar V, Dutta A, Ramasamy S, et al. Sting pathway - A futuristic therapeutic target for acute pancreatitis? Gene. 2021;778:145469. doi:10.1016/j.gene.2021.145469
  • Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111. doi:10.1136/gutjnl-2012-302779
  • Boxhoorn L, Voermans RP, Bouwense SA, et al. Acute pancreatitis. Lancet. 2020;396(10252):726–734. doi:10.1016/S0140-6736(20)31310-6
  • Garg PK, Singh VP. Organ failure due to systemic injury in acute pancreatitis. Gastroenterology. 2019;156(7):2008–2023. doi:10.1053/j.gastro.2018.12.041
  • Waller A, Long B, Koyfman A, et al. Acute pancreatitis: updates for emergency clinicians. J Emerg Med. 2018;55(6):769–779. doi:10.1016/j.jemermed.2018.08.009
  • Cienfuegos JA, Valentí V, Rotellar F. Acute pancreatitis: an opportunity for gastroenterology hospitalists? Rev Esp Enferm Dig. 2022;114(2):73–75. doi:10.17235/reed.2022.8573/2022
  • Hines OJ, Pandol SJ. Management of severe acute pancreatitis. BMJ. 2019;367:l6227. doi:10.1136/bmj.l6227
  • Vishnupriya K, Chanmugam A. Acute pancreatitis: the increasing role of medical management of a traditionally surgically managed disease. Am J Med. 2022;135(2):167–172. doi:10.1016/j.amjmed.2021.08.021
  • Valverde-López F, Martínez-Cara JG, Redondo-Cerezo E. Acute pancreatitis. Med Clin. 2022;158(11):556–563. doi:10.1016/j.medcli.2021.12.012
  • Gliem N, Ammer-Herrmenau C, Ellenrieder V, et al. Management of severe acute pancreatitis: an update. Digestion. 2021;102(4):503–507. doi:10.1159/000506830
  • Zhou H, Mei X, He X, et al. Severity stratification and prognostic prediction of patients with acute pancreatitis at early phase: a retrospective study. Medicine. 2019;98(16):e15275. doi:10.1097/MD.0000000000015275
  • Mederos MA, Reber HA, Girgis MD. Acute pancreatitis: a review. JAMA. 2021;325(4):382–390. doi:10.1001/jama.2020.20317
  • Zhang JN, Gao Y, Wang XT, et al. Lymphocyte-C-reactive protein ratio can differentiate disease severity of COVID-19 patients and serve as an assistant screening tool for hospital and ICU admission. Front Immunol. 2022;13:957407. doi:10.3389/fimmu.2022.957407
  • Lu LH, Zhong C, Wei W, et al. Lymphocyte-C-reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: a multicentre cohort study. Liver Int. 2021;41(2):378–387. doi:10.1111/liv.14567
  • Yildirim M, Koca B. Lymphocyte C-reactive protein ratio: a new biomarker to predict early complications after gastrointestinal oncologic surgery. Cancer Biomark. 2021;31(4):409–417. doi:10.3233/CBM-210251
  • Yugawa K, Maeda T, Kinjo N, et al. Prognostic impact of lymphocyte-c-reactive protein ratio in patients who underwent surgical resection for hepatocellular carcinoma. J Gastrointest Surg. 2022;26(1):104–112. doi:10.1007/s11605-021-05085-z
  • Erdogan A, Can FE, Gönüllü H. Evaluation of the prognostic role of NLR, LMR, PLR, and LCR ratio in COVID-19 patients. J Med Virol. 2021;93(9):5555–5559. doi:10.1002/jmv.27097
  • Wang J, Xie L, Lyu P, et al. Short-term prognostic efficacy of mGPS and LCS in patients with acute heart failure. Front Cardiovasc Med. 2022;9:944424. doi:10.3389/fcvm.2022.944424
  • Zhou W, Dong S, Chen Z, et al. New challenges for microRNAs in acute pancreatitis: progress and treatment. J Transl Med. 2022;20(1):192. doi:10.1186/s12967-022-03338-2
  • Beyer G, Hoffmeister A, Lorenz P, et al. Clinical practice guideline—acute and chronic pancreatitis. Dtsch Arztebl Int. 2022;119(29–30):495–501. doi:10.3238/arztebl.m2022.0223
  • Wang G, Xiao H, Ren E. Expert consensus on emergency diagnosis and treatment of acute pancreatitis. Clin Hepatol. 2021;37(5):1034–1041.
  • Lee PJ, Papachristou GI. New insights into acute pancreatitis. Nat Rev Gastroenterol Hepatol. 2019;16(8):479–496. doi:10.1038/s41575-019-0158-2
  • Ruan Q, Lu H, Zhu H, et al. A network-regulative pattern in the pathogenesis of kidney injury following severe acute pancreatitis. Biomed Pharmacother. 2020;125:109978. doi:10.1016/j.biopha.2020.109978
  • Ge P, Luo Y, Okoye CS, et al. Intestinal barrier damage, systemic inflammatory response syndrome, and acute lung injury: a troublesome trio for acute pancreatitis. Biomed Pharmacother. 2020;132:110770. doi:10.1016/j.biopha.2020.110770
  • Matta B, Gougol A, Gao X, et al. Worldwide variations in demographics, management, and outcomes of acute pancreatitis. Clin Gastroenterol Hepatol. 2020;18(7):1567–1575.e2. doi:10.1016/j.cgh.2019.11.017
  • Okugawa Y, Toiyama Y, Yamamoto A, et al. Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer. Ann Surg. 2020;272(2):342–351. doi:10.1097/SLA.0000000000003239
  • Yildirim M, Dasiran F, Angin YS, et al. Lymphocyte-C-reactive protein ratio: a putative predictive factor for intestinal ischemia in strangulated abdominal wall hernias. Hernia. 2021;25(3):733–739. doi:10.1007/s10029-020-02174-x
  • Cheng CB, Zhang QX, Zhuang LP, et al. Prognostic value of lymphocyte-to-C-reactive protein ratio in patients with gastric cancer after surgery: a multicentre study. Jpn J Clin Oncol. 2020;50(10):1141–1149. doi:10.1093/jjco/hyaa099
  • Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. J Med Virol. 2020;92(10):1733–1734. doi:10.1002/jmv.25819
  • Ni HH, Lu Z, Huang X, et al. Combining pre- and postoperative lymphocyte-c-reactive protein ratios can better predict hepatocellular carcinoma prognosis after partial hepatectomy. J Inflamm Res. 2022;15:2229–2241. doi:10.2147/JIR.S359498
  • Akdur G, Bardakçı O, Das M, et al. Diagnostic utility of hematological indices in predicting adverse outcomes and severity of acute pancreatitis based on BISAP and modified Glasgow score. Ulus Travma Acil Cerrahi Derg. 2022;28(3):268–275. doi:10.14744/tjtes.2020.26348
  • Junare PR, Debnath P, Nair S, et al. Complete hemogram: simple and cost-effective in staging and predicting outcome in acute pancreatitis. Wien Klin Wochenschr. 2021;133(13–14):661–668. doi:10.1007/s00508-021-01821-2
  • Malheiro F, Nascimento ML, Carmo A, et al. Circulating blood lymphocytes and acute pancreatitis severity: a systematic review. Cureus. 2023;15(10):e47532. doi:10.7759/cureus.47532
  • Langmead C, Lee PJ, Paragomi P, et al. A novel 5-cytokine panel outperforms conventional predictive markers of persistent organ failure in acute pancreatitis. Clin Transl Gastroenterol. 2021;12(5):e00351. doi:10.14309/ctg.0000000000000351
  • Paragomi P, Spagnolo DM, Breze CR, et al. Introduction and validation of a novel acute pancreatitis digital tool: interrogating large pooled data from 2 prospectively ascertained cohorts. Pancreas. 2020;49(10):1276–1282. doi:10.1097/MPA.0000000000001686
  • Komara NL, Paragomi P, Greer PJ, et al. Severe acute pancreatitis: capillary permeability model linking systemic inflammation to multiorgan failure. Am J Physiol Gastrointest Liver Physiol. 2020;319(5):G573–G583. doi:10.1152/ajpgi.00285.2020